B Capital, a global multi-stage investment firm, has closed the inaugural B Capital Healthcare Fund I which, in conjunction with B Capital Growth Fund III, gives the the firm over $500 million to invest in opportunities across the healthcare sector, from digital health to biotech.
The B Capital Healthcare team, led by managing director and general partner Robert Mittendorff, is focused on deploying capital to companies that are building breakthrough products and solutions shaping the future of healthcare.
The current B Capital global healthcare portfolio includes over 20 companies in the US, Asia and Europe, spanning early venture to late growth venture, across healthtech, digital health, biotech and medtech.
In January 2023, B Capital announced the close of Growth Fund III and affiliated funds with aggregate capital commitments of approximately $2.1 billion. With these fund closes, B Capital’s total assets under management are approximately $6.3 billion.
